Li et al[11]has reported mesothelin significantly increased tumor cell proliferation in MIA PaCa-2(mutant p53)human pancreatic cancer cell, and mesothelin shRNA significantly decreased tumor cell proliferation in BxPC-3 (mutant p53)human pancreatic cancer cell in vivo and vitro. Here, MSLN is linked to pancreatic neoplasm.